Jason Hoitt

Companies

• Stoke Therapeutics, Inc.Chief Patient Officer Jun 23, 2025 to now¹
• Provention Bio, Inc.Chief Commercial Officer Jan 8, 2020 to Apr 27, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STStoke Therapeutics, Inc. STOK10,276 shares³$250.6K at $24.39Mar 18, 2026
• PBProvention Bio, Inc.0 shares⁴Feb 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 18, 2026Sold 30 shares at $32.85 of Stoke Therapeutics, Inc.³
• Mar 18, 2026Sold 139 shares at $31.79 of Stoke Therapeutics, Inc.³
• Mar 18, 2026Sold 1,762 shares at $31.28 of Stoke Therapeutics, Inc.³
• Mar 17, 2026Sold 748 shares at $33.38 of Stoke Therapeutics, Inc.³
• Mar 17, 2026Sold 1,033 shares at $32.74 of Stoke Therapeutics, Inc.³
• Mar 15, 2026Exercised options 10,000 shares of Stoke Therapeutics, Inc.⁵
• Feb 10, 2023Sold 4,500 shares at $10.00 of Provention Bio, Inc.⁴